Nainital News Flash

Aortic Stenosis Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies

Aortic Stenosis Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies

November 08
20:38 2021
Aortic Stenosis Market Analysis: Insights into Epidemiology Segmentation, Treatment Landscape, Pipeline Therapies and Key Companies
Aortic Stenosis Market
Extensive research and development activities by pharmaceutical companies such as MyoKardia, Cytokinetics, and others and the anticipated launch of approved therapies and others will drive Aortic Stenosis market growth during the forecast period, i.e., 2021-2030.

DelveInsight’s Aortic Stenosis market report offers comprehensive coverage of the current treatment practices, pipeline therapies, and market share of the individual drug, current and forecasted Aortic Stenosis market size from 2018 to 2030 in the 7MM.

Some of the Key Highlights from the Aortic Stenosis Market Report

  • Aortic stenosis is the most common type of valvular heart disease in Europe and the second most common in the United States.

  • According to a study by Pujari et al. (2021), the calcific aortic stenosis prevalence is approximately 1% to 2% in patients aged 65 or more, 12% in patients aged 65 or more, and about 3.4% of patients aged greater than 75 have severe aortic stenosis.

  • Leading players such as MyoKardia, Cytokinetics, and others are working diligently towards developing novel therapies for Aortic Stenosis treatment.

  • Key Aortic Stenosis therapies in the pipeline include Mavacamten, CK-274, and others.

  • Mavacamten (MyoKardia) has been designated as a breakthrough therapy and an orphan drug by the US FDA for the potential treatment of symptomatic, obstructive HCM.

For further information related to disease, request for the sample @ Aortic Stenosis Market Outlook

Aortic Stenosis Overview

Aortic Stenosis is the obstruction of blood flow across the aortic valve. Mortality from the onset of symptoms is approximately 25% at one year and 50% at two years in symptomatic patients with medically treated moderate-to-severe aortic stenosis. Symptoms of aortic stenosis usually appear gradually after an asymptomatic latent period of 10-20 years.

Aortic Stenosis Epidemiology Segmentation

The Aortic Stenosis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Aortic Stenosis Prevalent Cases 

  • Aortic Stenosis Gender-Specific Cases 

  • Aortic Stenosis Age-Specific Cases 

Aortic Stenosis Treatment Landscape 

There are no approved medications to reverse or slow the progression of Aortic Stenosis. Still, medications such as statins, lipid-lowering therapies, and ACE inhibitor therapies are used to manage the disease symptomatically. The current major options for Aortic Stenosis treatment include Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), and Percutaneous Balloon Valvuloplasty

Aortic Stenosis Market Outlook

Extensive research and development activities by pharmaceutical companies such as MyoKardia, Cytokinetics, and others and the anticipated launch of approved therapies such as Mavacamten, CK-274, and others will drive Aortic Stenosis market growth during the forecast period, i.e., 2021–2030.

Get a detailed analysis of the market @ Aortic Stenosis Market Analysis

Aortic Stenosis Pipeline Therapie and Key Companies 

  • Mavacamten: MyoKardia

  • CK-274: Cytokinetics

Table of Contents 

1.

Report Introduction

2.

Aortic Stenosis (AS) Market Overview at a Glance

3.

Disease Background and Overview: Aortic Stenosis (AS)  

4.

Aortic Stenosis Epidemiology and Patient Population

5.

Aortic Stenosis Treatments & Medical Practices

6.

Aortic Stenosis Marketed Therapy

7.

Aortic Stenosis Emerging Therapies

8.

Key Cross Competition

9.

Aortic Stenosis (AS)  Market Size

10.

Aortic Stenosis (AS): Country-Wise Market Analysis

11.

Aortic Stenosis United States Market Size

12.

Aortic Stenosis Germany Market Size

13.

Aortic Stenosis France Market Size

14.

Aortic Stenosis Italy Market Size

15.

Aortic Stenosis Spain Market Size

16.

Aortic Stenosis United Kingdom Market Size

17.

Aortic Stenosis Japan Market Size

18.

Report Methodology

19.

DelveInsight Capabilities

20.

Disclaimer

21.

About DelveInsight

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Abdominal Aortic Aneurysm Market

DelveInsight’s “Abdominal Aortic Aneurysm – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the 7MM.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

About Author

admin

admin